Intracranial paragangliomas versus schwannomas: Role of dynamic susceptibility contrast perfusion and diffusion MRI

BACKGROUND AND PURPOSE: Differentiating paragangliomas from schwannomas and distinguishing sporadic from neurofibromatosis type 2 (NF 2)‐related schwannomas is challenging but clinically important. This study aimed to assess the utility of dynamic susceptibility contrast perfusion MRI (DSC‐MRI) and diffusion‐weighted imaging (DWI) in discriminating infratentorial extra‐axial schwannomas from paragangliomas and NF2‐related schwannomas. METHODS: This retrospective study included 41 patients diagnosed with paragangliomas, sporadic schwannomas, and NF2‐related schwannomas in the infratentorial extra‐axial space between April 2013 and August 2021. All cases had pretreatment DSC‐MRI and DWI. Normalized mean apparent diffusion coefficient (nADCmean), normalized relative cerebral blood volume (nrCBV), and normalized relative cerebral blood flow (nrCBF) were compared between paragangliomas and schwannomas and between sporadic and NF2‐related schwannomas as appropriate. RESULTS: nrCBV and nrCBF were significantly higher in paragangliomas than in sporadic/NF2‐related schwannomas (nrCBV: median 11.5 vs. 1.14/3.74; p < .001 and .004, nrCBF: median 7.43 vs. 1.13/2.85; p < .001 and .007, respectively), while nADCmean were not. The corresponding diagnostic performances were area under the curves (AUCs) of .99/.92 and 1.0/.90 with cutoffs of 2.56/4.22 and 1.94/3.36, respectively. nADCmean were lower, and nrCBV and nrCBF were higher in NF2‐related than in sporadic schwannomas (nADCmean: median 1.23 vs. 1.58, nrCBV: median 3.74 vs. 1.14, nrCBF: median 2.85 vs. 1.13; all p < .001), and the corresponding diagnostic performances were AUCs of .93, .91, and .95 with cutoffs of 1.37, 2.63, and 2.48, respectively. CONCLUSIONS: DSC‐MRI and DWI both can aid in differentiating paragangliomas from schwannomas and sporadic from NF2‐related schwannomas.